TY - JOUR AU - Bonetti, P. O. AU - Lerman, L. O. AU - Lerman, A. PY - 2003 DA - 2003// TI - Endothelial dysfunction: a marker of atherosclerotic risk JO - Arterioscler Thromb Vasc Biol VL - 23 UR - https://doi.org/10.1161/01.ATV.0000051384.43104.FC DO - 10.1161/01.ATV.0000051384.43104.FC ID - Bonetti2003 ER - TY - JOUR AU - Lerman, A. AU - Sandok, E. K. AU - Hildebrand, F. L. AU - Burnett, J. C. PY - 1992 DA - 1992// TI - Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction JO - Circulation VL - 85 UR - https://doi.org/10.1161/01.CIR.85.5.1894 DO - 10.1161/01.CIR.85.5.1894 ID - Lerman1992 ER - TY - JOUR AU - Anderson, T. J. PY - 1999 DA - 1999// TI - Assessment and treatment of endothelial dysfunction in humans JO - J Am Coll Cardiol VL - 34 UR - https://doi.org/10.1016/S0735-1097(99)00259-4 DO - 10.1016/S0735-1097(99)00259-4 ID - Anderson1999 ER - TY - JOUR AU - Bonetti, P. O. AU - Barsness, G. W. AU - Keelan, P. C. AU - Schnell, T. I. AU - Pumper, G. M. AU - Kuvin, J. T. PY - 2003 DA - 2003// TI - Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease JO - J Am Coll Cardiol VL - 41 UR - https://doi.org/10.1016/S0735-1097(03)00329-2 DO - 10.1016/S0735-1097(03)00329-2 ID - Bonetti2003 ER - TY - JOUR AU - Al Suwaidi, J. AU - Hamasaki, S. AU - Higano, S. T. AU - Nishimura, R. A. AU - Holmes, D. R. AU - Lerman, A. PY - 2000 DA - 2000// TI - Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction JO - Circulation VL - 101 UR - https://doi.org/10.1161/01.CIR.101.9.948 DO - 10.1161/01.CIR.101.9.948 ID - Al Suwaidi2000 ER - TY - JOUR AU - Flammer, A. J. AU - Anderson, T. AU - Celermajer, D. S. AU - Creager, M. A. AU - Deanfield, J. AU - Ganz, P. PY - 2012 DA - 2012// TI - The assessment of endothelial function from research into clinical practice JO - Circulation VL - 126 UR - https://doi.org/10.1161/CIRCULATIONAHA.112.093245 DO - 10.1161/CIRCULATIONAHA.112.093245 ID - Flammer2012 ER - TY - JOUR AU - Kuvin, J. T. AU - Patel, A. R. AU - Sliney, K. A. AU - Pandian, N. G. AU - Sheffy, J. AU - Schnall, R. P. PY - 2003 DA - 2003// TI - Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude JO - Am Heart J VL - 146 UR - https://doi.org/10.1016/S0002-8703(03)00094-2 DO - 10.1016/S0002-8703(03)00094-2 ID - Kuvin2003 ER - TY - JOUR AU - Bonetti, P. AU - Pumper, G. AU - Higano, S. AU - Holmes, D. AU - Kuvin, J. AU - Lerman, A. PY - 2004 DA - 2004// TI - Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia JO - J Am Coll Cardiol VL - 44 UR - https://doi.org/10.1016/j.jacc.2004.08.062 DO - 10.1016/j.jacc.2004.08.062 ID - Bonetti2004 ER - TY - JOUR AU - Li, S. AU - Wu, Y. AU - Yu, G. AU - Xia, Q. AU - Yawei, X. PY - 2014 DA - 2014// TI - Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0090217 DO - 10.1371/journal.pone.0090217 ID - Li2014 ER - TY - JOUR AU - Watanabe, T. AU - Barker, T. A. AU - Berk, B. C. PY - 2005 DA - 2005// TI - Angiotensin II and the endothelium: diverse signals and effects JO - Hypertension VL - 45 UR - https://doi.org/10.1161/01.HYP.0000153321.13792.b9 DO - 10.1161/01.HYP.0000153321.13792.b9 ID - Watanabe2005 ER - TY - JOUR AU - Negro, R. PY - 2008 DA - 2008// TI - Endothelial effects of antihypertensive treatment: focus on irbesartan JO - Vasc Health Risk Manag VL - 4 UR - https://doi.org/10.2147/vhrm.2008.04.01.89 DO - 10.2147/vhrm.2008.04.01.89 ID - Negro2008 ER - TY - JOUR AU - Beigel, R. AU - Dvir, D. AU - Arbel, Y. AU - Shechter, A. AU - Feinberg, M. S. AU - Shechter, M. PY - 2010 DA - 2010// TI - Pulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease JO - Vasc Med VL - 15 UR - https://doi.org/10.1177/1358863X10373300 DO - 10.1177/1358863X10373300 ID - Beigel2010 ER - TY - JOUR AU - Ceravolo, R. AU - Maio, R. AU - Pujia, A. AU - Sciacqua, A. AU - Ventura, G. AU - Costa, M. C. PY - 2003 DA - 2003// TI - Pulse pressure and endothelial dysfunction in never-treated hypertensive patients JO - J Am Coll Cardiol VL - 41 UR - https://doi.org/10.1016/S0735-1097(03)00295-X DO - 10.1016/S0735-1097(03)00295-X ID - Ceravolo2003 ER - TY - JOUR AU - Meyer, G. AU - Herman, A. PY - 1997 DA - 1997// TI - Vascular endothelial dysfunction JO - Prog Cardiovasc Dis VL - 39 UR - https://doi.org/10.1016/S0033-0620(97)80031-X DO - 10.1016/S0033-0620(97)80031-X ID - Meyer1997 ER - TY - JOUR AU - Ichigi, Y. AU - Takano, H. AU - Umetani, K. AU - Kawabata, K. AU - Obata, J. E. AU - Kitta, Y. PY - 2005 DA - 2005// TI - Increased ambulatory pulse pressure is a strong risk factor for coronary endothelial vasomotor dysfunction JO - J Am Coll Cardiol VL - 45 UR - https://doi.org/10.1016/j.jacc.2005.01.038 DO - 10.1016/j.jacc.2005.01.038 ID - Ichigi2005 ER - TY - JOUR AU - Mombouli, J. V. PY - 1997 DA - 1997// TI - ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide JO - Drugs VL - 54 UR - https://doi.org/10.2165/00003495-199700545-00004 DO - 10.2165/00003495-199700545-00004 ID - Mombouli1997 ER - TY - JOUR AU - Baxter, G. AU - Ebrahim, Z. PY - 2002 DA - 2002// TI - Role of bradykinin in preconditioning and protection of the ischaemic myocardium JO - Br J Pharmacol VL - 135 UR - https://doi.org/10.1038/sj.bjp.0704548 DO - 10.1038/sj.bjp.0704548 ID - Baxter2002 ER - TY - JOUR AU - Levy, B. I. PY - 2005 DA - 2005// TI - How to explain the differences between renin angiotensin system modulators JO - Am J Hypertens VL - 18 UR - https://doi.org/10.1016/j.amjhyper.2005.05.005 DO - 10.1016/j.amjhyper.2005.05.005 ID - Levy2005 ER - TY - JOUR AU - Tsutsumi, Y. AU - Matsubara, H. AU - Masaki, H. AU - Kurihara, H. AU - Murasawa, S. AU - Takai, S. PY - 1999 DA - 1999// TI - Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation JO - J Clin Invest VL - 104 UR - https://doi.org/10.1172/JCI7886 DO - 10.1172/JCI7886 ID - Tsutsumi1999 ER - TY - JOUR AU - Tea, B. S. AU - Sarkissian, S. AU - Touyz, R. M. AU - Hamet, P. PY - 2000 DA - 2000// TI - deBlois D. Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo JO - Hypertension VL - 35 UR - https://doi.org/10.1161/01.HYP.35.5.1069 DO - 10.1161/01.HYP.35.5.1069 ID - Tea2000 ER - TY - JOUR AU - Senbonmatsu, T. AU - Saito, T. AU - Landon, E. J. AU - Watanabe, O. AU - Price, E. AU - Roberts, R. L. PY - 2003 DA - 2003// TI - A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy JO - EMBO J VL - 22 UR - https://doi.org/10.1093/emboj/cdg637 DO - 10.1093/emboj/cdg637 ID - Senbonmatsu2003 ER - TY - JOUR AU - Verma, S. AU - Strauss, M. PY - 2004 DA - 2004// TI - Angiotensin receptor blockers and myocardial infarction JO - BMJ VL - 329 UR - https://doi.org/10.1136/bmj.329.7477.1248 DO - 10.1136/bmj.329.7477.1248 ID - Verma2004 ER - TY - JOUR AU - Julius, S. AU - Kjeldsen, S. E. AU - Weber, M. AU - Brunner, H. R. AU - Ekman, S. AU - Hansson, L. PY - 2004 DA - 2004// TI - Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial JO - Lancet VL - 363 UR - https://doi.org/10.1016/S0140-6736(04)16451-9 DO - 10.1016/S0140-6736(04)16451-9 ID - Julius2004 ER - TY - JOUR AU - Strauss, M. H. AU - Hall, A. S. PY - 2006 DA - 2006// TI - Angiotensin receptor blockers may increase risk of myocardial infarction unraveling the ARB-MI paradox JO - Circulation VL - 114 UR - https://doi.org/10.1161/CIRCULATIONAHA.105.594986 DO - 10.1161/CIRCULATIONAHA.105.594986 ID - Strauss2006 ER - TY - JOUR AU - Tsuyuki, R. T. AU - McDonald, M. A. PY - 2006 DA - 2006// TI - Angiotensin receptor blockers do not increase risk of myocardial infarction JO - Circulation VL - 114 UR - https://doi.org/10.1161/CIRCULATIONAHA.105.594978 DO - 10.1161/CIRCULATIONAHA.105.594978 ID - Tsuyuki2006 ER - TY - JOUR AU - Collaboration, B. P. L. T. T. PY - 2007 DA - 2007// TI - Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system JO - J Hypertens VL - 25 UR - https://doi.org/10.1097/HJH.0b013e3280bad9b4 DO - 10.1097/HJH.0b013e3280bad9b4 ID - Collaboration2007 ER - TY - JOUR AU - Investigators, T. O. PY - 2008 DA - 2008// TI - Telmisartan, ramipril, or both in patients at high risk for vascular Events JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa0801317 DO - 10.1056/NEJMoa0801317 ID - Investigators2008 ER - TY - JOUR AU - Ghiadoni, L. AU - Magagna, A. AU - Versari, D. AU - Kardasz, I. AU - Huang, Y. AU - Taddei, S. PY - 2003 DA - 2003// TI - Different effect of antihypertensive drugs on conduit artery endothelial function JO - Hypertension VL - 41 UR - https://doi.org/10.1161/01.HYP.0000070956.57418.22 DO - 10.1161/01.HYP.0000070956.57418.22 ID - Ghiadoni2003 ER - TY - JOUR AU - Hornig, B. AU - Landmesser, U. AU - Kohler, C. AU - Ahlersmann, D. AU - Spiekermann, S. AU - Christoph, A. PY - 2001 DA - 2001// TI - Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase JO - Circulation VL - 103 UR - https://doi.org/10.1161/01.CIR.103.6.799 DO - 10.1161/01.CIR.103.6.799 ID - Hornig2001 ER -